Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Amortization - Intangibles: 2023-2025

Historic Amortization - Intangibles for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $752,000.

  • Prime Medicine's Amortization - Intangibles fell 15.03% to $752,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 55.47%. This contributed to the annual value of $3.5 million for FY2024, which is 38.22% down from last year.
  • Per Prime Medicine's latest filing, its Amortization - Intangibles stood at $752,000 for Q3 2025, which was up 41.89% from $530,000 recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Amortization - Intangibles registered a high of $1.8 million during Q3 2023, and its lowest value of $306,000 during Q4 2024.
  • Over the past 3 years, Prime Medicine's median Amortization - Intangibles value was $824,000 (recorded in 2023), while the average stood at $884,100.
  • Examining YoY changes over the last 5 years, Prime Medicine's Amortization - Intangibles showed a top increase of 81.66% in 2024 and a maximum decrease of 72.82% in 2024.
  • Over the past 3 years, Prime Medicine's Amortization - Intangibles (Quarterly) stood at $1.1 million in 2023, then tumbled by 72.82% to $306,000 in 2024, then decreased by 15.03% to $752,000 in 2025.
  • Its Amortization - Intangibles was $752,000 in Q3 2025, compared to $530,000 in Q2 2025 and $339,000 in Q1 2025.